MDAI on Nasdaq
Spectral AI, Inc.
American surgical and medical instruments and apparatus company. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Sonoma Pharmaceuticals, Inc., NEPHROS INC or Vivos Therapeutics, Inc., or pick any stock.
- TickerMDAI on Nasdaq1
- IndustrySurgical & Medical Instruments & Apparatus1
- HeadquartersDallas, Texas1
- Incorporated inDE2
- Business address2515 Mckinney Ave #1000, Dallas, Tx 752012
- Filer category, Emerging growth company2
See how the biggest companies compare on our leaderboards
PBS contract. Completion of these contractual phases support our long-term goal of entering a federal procurement contract with BARDA.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue55¢$10.7M
- Other costs45¢$8.9M
- Income tax0¢$11.0K
Out of $19.6M in revenue.4 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Research and development revenue | $19.6M | $29.6M |
| Cost of revenue | -$10.7M | -$16.3M |
| Gross profit | $8.9M | $13.3M |
| General and administrative | $17.5M | $19.9M |
| Total operating costs and expenses | $17.5M | $19.9M |
| Operating loss | -$8.6M | -$6.6M |
| Net interest (expense) income | -$886.0K | $14.0K |
| Financing related costs | -$1.1M | -$3.0M |
| Amortization of debt discount | -$455.0K | |
| Change in fair value of warrant liabilities | $3.2M | -$4.6M |
| Change in fair value of notes payable | $220.0K | -$220.0K |
| Foreign exchange transaction loss, net | -$34.0K | -$43.0K |
| Other expenses, including transaction costs | -$615.0K | |
| Total other income (expense), net | $1.0M | -$8.5M |
| Loss before income taxes | -$7.6M | -$15.0M |
| Income tax provision | -$11.0K | -$114.0K |
| Net loss | -$7.6M | -$15.2M |
| Basic (in Dollars per share) | -$0.29 | -$0.85 |
| Diluted (in Dollars per share) | -$0.29 | -$0.85 |
| Basic (in Shares) | 26.5M shares | 17.9M shares |
| Diluted (in Shares) | 26.5M shares | 17.9M shares |
| Foreign currency translation adjustments | $37.0K | -$9.0K |
| Total comprehensive loss | -$7.5M | -$15.2M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash | $15.4M | $5.2M | $4.6M | |
| Accounts receivable, net | $1.3M | $2.5M | ||
| Inventory | $838.0K | $425.0K | ||
| Prepaid expenses | $821.0K | $1.3M | ||
| Other current assets | $1.1M | $746.0K | ||
| Total current assets | $19.5M | $10.1M | ||
| Property and equipment, net | $258.0K | $2.0K | ||
| Right-of-use assets | $1.4M | $2.0M | ||
| Other assets | $287.0K | |||
| Total Assets | $21.4M | $12.1M | ||
| Accounts payable | $3.0M | $4.0M | ||
| Accrued expenses | $2.3M | $3.2M | ||
| Deferred revenue | $154.0K | $960.0K | ||
| Lease liabilities, short-term | $734.0K | $201.0K | ||
| Notes payable | $2.9M | $422.0K | ||
| Notes payable at fair value | $2.4M | |||
| Warrant liabilities | $11.5M | $6.5M | ||
| Total current liabilities | $20.6M | $17.6M | ||
| Notes payable, long-term | $5.5M | |||
| Lease liabilities, long-term | $968.0K | $1.7M | ||
| Total Liabilities | $27.1M | $19.3M | ||
| Common stock ($0.0001 par value); 80,000,000 shares authorized; 30,688,895 and 22,594,877 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | $3.0K | $2.0K | ||
| Additional paid-in capital | $50.0M | $41.0M | ||
| Accumulated other comprehensive income | $40.0K | $3.0K | ||
| Accumulated deficit | -$55.8M | -$48.2M | ||
| Total Stockholders Deficit | -$5.7M | -$7.3M | -$2.1M | |
| Total Liabilities and Stockholders Deficit | $21.4M | $12.1M | ||
| Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in Shares) | 1.0M shares | 1.0M shares | ||
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in Shares) | 80.0M shares | 80.0M shares | ||
| Common stock, shares issued (in Shares) | 30.7M shares | 22.6M shares | ||
| Common stock, shares outstanding (in Shares) | 30.7M shares | 22.6M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
| Cash | $15.4M | $5.2M | $4.6M | |
| Accounts receivable, net | $1.3M | $2.5M | ||
| Inventory | $838.0K | $425.0K | ||
| Prepaid expenses | $821.0K | $1.3M | ||
| Other current assets | $1.1M | $746.0K | ||
| Total current assets | $19.5M | $10.1M | ||
| Property and equipment, net | $258.0K | $2.0K | ||
| Right-of-use assets | $1.4M | $2.0M | ||
| Other assets | $287.0K | |||
| Total Assets | $21.4M | $12.1M | ||
| Accounts payable | $3.0M | $4.0M | ||
| Accrued expenses | $2.3M | $3.2M | ||
| Deferred revenue | $154.0K | $960.0K | ||
| Lease liabilities, short-term | $734.0K | $201.0K | ||
| Notes payable | $2.9M | $422.0K | ||
| Notes payable at fair value | $2.4M | |||
| Warrant liabilities | $11.5M | $6.5M | ||
| Total current liabilities | $20.6M | $17.6M | ||
| Notes payable, long-term | $5.5M | |||
| Lease liabilities, long-term | $968.0K | $1.7M | ||
| Total Liabilities | $27.1M | $19.3M | ||
| Common stock ($0.0001 par value); 80,000,000 shares authorized; 30,688,895 and 22,594,877 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | $3.0K | $2.0K | ||
| Additional paid-in capital | $50.0M | $41.0M | ||
| Accumulated other comprehensive income | $40.0K | $3.0K | ||
| Accumulated deficit | -$55.8M | -$48.2M | ||
| Total Stockholders Deficit | -$5.7M | -$7.3M | -$2.1M | |
| Total Liabilities and Stockholders Deficit | $21.4M | $12.1M | ||
| Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in Shares) | 1.0M shares | 1.0M shares | ||
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in Shares) | 80.0M shares | 80.0M shares | ||
| Common stock, shares issued (in Shares) | 30.7M shares | 22.6M shares | ||
| Common stock, shares outstanding (in Shares) | 30.7M shares | 22.6M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$7.6M | -$15.2M |
| Depreciation expense | $71.0K | $10.0K |
| Amortization of debt issuance costs | $454.0K | |
| Stock-based compensation | $1.1M | $1.0M |
| Amortization of right-of-use assets | $564.0K | $578.0K |
| Change in fair value of warrant liabilities | -$3.2M | $4.6M |
| Change in fair value of notes payable | -$220.0K | $220.0K |
| Costs from issuance of common stock | $372.0K | |
| Issuance of shares for borrowing related costs | $241.0K | $1.1M |
| Transaction costs allocated to Avenue Warrants, Investor Warrants, and Hudson Warrants | $704.0K | |
| Accounts receivable | $1.2M | -$159.0K |
| Inventory | -$413.0K | -$195.0K |
| Prepaid expenses | $761.0K | $163.0K |
| Other assets | -$387.0K | -$102.0K |
| Accounts payable | -$1.0M | $1.4M |
| Accrued expenses | -$869.0K | -$1.1M |
| Deferred revenue | -$806.0K | -$1.4M |
| Lease liabilities | -$528.0K | -$721.0K |
| Net cash used in operating activities | -$9.9M | -$9.2M |
| Proceeds from issuance of common stock and warrants | $10.6M | $4.1M |
| Payment of issuance costs | -$642.0K | |
| Proceeds from notes payable | $8.3M | $12.1M |
| Payment of borrowing costs | -$47.0K | |
| Proceeds from notes payable - related party | $1.0M | |
| Payments for notes payable | -$1.5M | -$7.8M |
| Proceeds from warrant exercises | $2.5M | |
| Stock option exercises | $889.0K | $177.0K |
| Net cash provided by financing activities | $20.1M | $9.6M |
| Effect of exchange rate changes on cash | $37.0K | -$9.0K |
| Net increase in cash | $10.2M | $367.0K |
| Cash paid for interest | $22.0K | $11.0K |
| Cash paid for taxes | $100.0K | $11.0K |
| Recognition of Right-of-use assets and related lease liabilities upon lease amendment | $1.8M | |
| Tenant improvement allowance payments made by the lessor directly to a third party | -$327.0K | |
| Issuance of common stock to settle accounts and notes payable | $1.2M | $3.2M |
| Short-term financing of insurance premium | -$580.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led Spectral AI, Inc., and when. Pick a name to see everywhere that person has worked.
President
Chief financial officer
Chief operating officer
- Chief executive officerVincent S. Capone Apr 6, 2026 to now11
- Chief executive officerPeter M. Carlson May 13, 2024 to May 13, 202412
- Chief executive officerWensheng Fan Sep 13, 2023 to Sep 13, 202313
- PresidentJordan Zimmerman Feb 11, 2021 to Feb 11, 202114
- Chief financial officerVincent S. Capone May 13, 2024 to now15
- Chief financial officerNils Windler Sep 13, 2023 to Sep 13, 202316
- Chief financial officerKieran Goodwin Feb 11, 2021 to Feb 11, 202117
- Chief operating officerStan Micek May 14, 2024 to May 14, 202418
- Chief operating officerNikolaos Pagoulatos Sep 13, 2023 to Sep 13, 202319
Board members and other officers (16)
- Chief Commerical OfficerJeremiah A. Sparks May 13, 2024 to May 13, 202420
- CHIEF SCIENTISTJeffrey Edward Thatcher Sep 14, 2023 to Sep 14, 202321
- Board memberMarion Ann Snyder Apr 27, 2026 to now22
- Board memberDeepak Sadagopan May 20, 2026 to now23
- Board memberErich Spangenberg May 13, 2024 to May 17, 202424
- Board memberPeter M. Carlson May 13, 2024 to May 13, 202412
- Board memberMartin C.b. Mellish Sep 13, 2023 to now25
- Board memberRichard John Cotton Sep 13, 2023 to now26
- Board memberWensheng Fan Sep 13, 2023 to Sep 13, 202313
- Board memberXiaojia Cynthia Cai Sep 13, 2023 to Sep 13, 202327
- Board memberBrian J. Radecki Feb 11, 2021 to Sep 13, 202328
- Board memberFranklin S. Edmonds Jr. Feb 11, 2021 to Sep 13, 202329
- Board memberHeather Bellini Feb 11, 2021 to Sep 13, 202330
- Board memberJordan Zimmerman Feb 11, 2021 to Feb 11, 202114
- Board memberKieran Goodwin Feb 11, 2021 to Feb 11, 202117
- General counselVincent S. Capone Sep 13, 2023 to now31
Former names
- Rosecliff Acquisition Corp IDec 23, 2020 to Sep 13, 20232
Timeline
Filings
263 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 62 major events, 55 insider forms, 22 large holders, 104 other. The latest 20:
- Sep 29, 20264 EDGAR
- Sep 25, 20264 EDGAR
- Sep 21, 20264 EDGAR
- Sep 15, 20268-K CURRENT REPORT EDGAR
- Sep 14, 20264 EDGAR
- Aug 17, 20264 EDGAR
- Aug 14, 2026SCHEDULE 13G EDGAR
- Aug 12, 20268-K CURRENT REPORT EDGAR
- Aug 11, 202610-Q QUARTERLY REPORT EDGAR
- Jul 8, 20268-K CURRENT REPORT EDGAR
- Jun 29, 20264 EDGAR
- Jun 1, 20268-K CURRENT REPORT EDGAR
- Jun 1, 20264 EDGAR
- May 27, 20264 EDGAR
- May 26, 20268-K CURRENT REPORT EDGAR
- May 20, 20264 EDGAR
- May 18, 20264 EDGAR
- May 18, 20264 EDGAR
- May 13, 202610-Q QUARTERLY REPORT EDGAR
- May 8, 2026SCHEDULE 13G/A EDGAR
The 263 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
6 open-market trades by officers, directors and large owners since October 2021: 6 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 10, 2024 | DiMaio John MichaelDirector | Buy | 6,000 | $1.72 | $10.3K | Form 4 |
| Nov 20, 2023 | DiMaio John MichaelDirector | Buy | 2,000 | $2.67 | $5.3K | Form 4 |
| Nov 16, 2023 | DiMaio John MichaelDirector | Buy | 500 | $2.68 | $1.3K | Form 4 |
| Nov 14, 2023 | DiMaio John MichaelDirector | Buy | 355 | $2.81 | $998 | Form 4 |
| Sep 13, 2023 | DiMaio John MichaelDirector | Buy | 198 | $5.07 | $1.0K | Form 4 |
| Sep 12, 2023 | DiMaio John MichaelDirector | Buy | 1,000 | $5.97 | $6.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- LMR Partners LLPSCHEDULE 13G, 1 filing Aug 14, 202632
- Hudson Bay Capital Management LPSCHEDULE 13G/A, 2 filings Feb 11, 2026 to May 8, 202633
- Erich SpangenbergSCHEDULE 13D/A, 4 filings Sep 27, 2023 to Mar 18, 202634
- Laurence E. HirschSCHEDULE 13G/A, 3 filings Nov 3, 2023 to Aug 14, 202535
- Octopus Investments Ltd.SC 13G/A, 2 filings Feb 8, 2024 to Nov 14, 202436
- John Michael DimaioSC 13D/A, 3 filings Sep 21, 2023 to Feb 27, 202437
- Beryl Capital Management LLCSC 13G/A, 2 filings Dec 8, 2022 to Feb 14, 202338
- GLAZER CAPITAL, LLCSC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 202339
- Saba Capital Management, L.P.SC 13G/A, 2 filings Feb 14, 2022 to Feb 14, 202340
- Rosecliff Acquisition Sponsor I LLCSC 13G, 1 filing Feb 14, 202241
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 34. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 994,410 | $1.7M | 0.0% | +268,120 |
| Highlander Partners, L.P. | 900,000 | $1.6M | 0.5% | No change |
| Marshall Wace, Llp | 827,454 | $1.4M | 0.0% | New |
| Bridgeway Capital Management, LLC | 287,000 | $496.5K | 0.0% | +88,000 |
| Jane Street Group, LLC | 226,319 | $391.5K | 0.0% | +5,318 |
| UBS Group AG | 225,823 | $390.7K | 0.0% | +112,803 |
| Geode Capital Management, LLC | 222,595 | $385.2K | 0.0% | −78,612 |
| BlackRock, Inc. | 161,777 | $279.9K | 0.0% | +39,523 |
| LPL Financial LLC | 160,701 | $278.0K | 0.0% | New |
| Vanguard Fiduciary Trust Co | 142,664 | $246.8K | 0.0% | +868 |
| University Of Texas/texas Am Investment Management Co | 121,711 | $210.6K | 0.0% | −88,777 |
| Rathbones Group PLC | 87,045 | $150.6K | 0.0% | −87,045 |
| State Street Corp | 75,600 | $130.8K | 0.0% | No change |
| Forum Financial Management, LP | 60,501 | $104.7K | 0.0% | No change |
| Northern Trust Corp | 50,547 | $87.4K | 0.0% | +18,449 |
| XTX Topco Ltd | 32,927 | $57.0K | 0.0% | +5,839 |
| N.E.W. Advisory Services LLC | 20,010 | $34.6K | 0.0% | +6,010 |
| Jpmorgan Chase & Co | 20,259 | $34.2K | 0.0% | New |
| StoneX Group Inc. | 15,343 | $31.6K | 0.0% | New |
| Royal Bank Of Canada | 15,452 | $27.0K | 0.0% | New |
| Morgan Stanley | 13,799 | $23.9K | 0.0% | +5,405 |
| Raymond James Financial Inc | 12,800 | $22.1K | 0.0% | No change |
| Tower Research Capital LLC (TRC) | 12,121 | $21.0K | 0.0% | New |
| Philip James Wealth Mangement, LLC | 12,000 | $20.8K | 0.0% | No change |
| Engineers Gate Manager LP | 11,046 | $19.1K | 0.0% | New |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARJordan Zimmerman, President
- 15
- 16
- 17
- 18SEC EDGARStan Micek, Chief operating officer
- 19
- 20
- 21
- 22SEC EDGARMarion Ann Snyder, Board member
- 23SEC EDGARDeepak Sadagopan, Board member
- 24SEC EDGARErich Spangenberg, Board member
- 25SEC EDGARMartin C.b. Mellish, Board member
- 26SEC EDGARRichard John Cotton, Board member
- 27SEC EDGARXiaojia Cynthia Cai, Board member
- 28SEC EDGARBrian J. Radecki, Board member
- 29
- 30SEC EDGARHeather Bellini, Board member
- 31SEC EDGARVincent S. Capone, General counsel
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41